Our Mission

Our Purpose

We want to discover, develop and successfully market innovative products to treat diseases, to ease suffering, and to enhance the quality of life.

We also want to provide shareholder returns that reflect outstanding performance and to reward adequately those who invest ideas and resources in our company.

 

Novartis is renowned for its commitment to:

• Innovative medicines – introducing new treatments annually
• Continued prime position in cardiology and oncology – blockbuster products
• Excellence in new product pipeline via research and development – one of the strongest in the industry with 75 products in the current pipeline
• Corporate responsibility in the UK and worldwide – in 2007, the Novartis access-to-medicines programmes, valued at USD 937m, reached 66 million patients globally
• Diversity and inclusion in employment